# Octapharma Plasma, Inc. – FDA Inspection, Oct 28, 2022

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/968d9f06-bf5e-4cdd-9935-7488a2e7e9c9
Source feed: FDA_Inspections

> FDA inspection 1191447 of Octapharma Plasma, Inc., October 28, 2022. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1191447
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2022-10-28
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1015098 - 2017-05-23
- FDA Inspection 935859 - 2015-07-23
- FDA Inspection 819769 - 2013-02-21
- FDA Inspection 722288 - 2011-05-02
- [FDA Inspection 660401 - 2010-05-06](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/3b66aa40-a402-4396-b814-c5739861456a)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/ce79a43a-da67-4e55-ba2a-ad6129607f59

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d